Treatment of perennial allergic rhinitis with lactic acid bacteria

Pediatric Allergy and Immunology

Volumn 15, Issue 2, 2004, Pages 152-158

  Wang, Ming Fuu ^a   Lin, Hsiao Chuan ^a   Wang, Ying Yu ^b   Hsu, Ching Hsiang ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b GenMont Biotec Inc   (Taiwan)

Author keywords

Allergic rhinitis; Lactic acid bacteria; Quality of life

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ABDOMINAL PAIN; ADOLESCENT; ALLERGIC RHINITIS; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FERMENTATION; FEVER; HUMAN; LACTIC ACID BACTERIUM; LACTOBACILLUS PARACASEI; LACTOBACILLUS PARACASEI 33; MALE; MILK; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; SIDE EFFECT;

ADOLESCENT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LACTOBACILLUS; MALE; PROBIOTICS; QUALITY OF LIFE; RHINITIS, ALLERGIC, PERENNIAL; TREATMENT OUTCOME;

EID: 1842683055     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2004.00156.x     Document Type: Article

References (21)

1. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998: 351: 1225-32.
2. BOUSQUET J, VAN CAUWENBERGE P, KHALTAEV N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001: 108: S147-S334.
3. BARNES K, MARSH D. The genetics and complexity of allergy and asthma. Immunol Today 1998: 19: 325-32.
4. STRACHAN DP. Hay fever, hygiene, and household size. Br Med J 1989: 299: 1259-60.
5. SUDO N, YU XN, AIBA Y, et al. An oral introduction of intestinal bacteria prevents the development of a long-term Th2 skewed immunological memory induced by the neonatal antibiotic treatment in mice. Clin Exp Allergy 2002: 32: 1112-16.
6. SUTAS Y, SOPPI E, KORHONEN H, et al. Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolyzed with Lactobacillus casei GG-derived enzymes. J Allergy Clin Immunol 1996: 98: 216-24.
7. BJÖRKSTÉN B, NAABER P, SEPP E, MIKELSAAR M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999: 29: 342-6.
8. BJÖRKSTÉN B, SEPP E, JULGE K, VOOR T, MIKELSAAR M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001: 108: 516-20.
9. POCHARD P, GOSSET P, GRANGETTE C, et al. Lactic acid bacteria inhibit Th2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol 2001: 110: 617-23.
10. KALLIMAKI M, SALMINEN S, ARVILOMMI H, KERO P, KOSKINEN P, ISOLAURI E. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet 2001: 357: 1076-9.
11. JUNIPER EF, HOWLAND WC, ROBERTS NB, THOMPSON AK, KING DR, MATH B. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol 1998: 101: 163-70.
12. MAJAMAA H, ISOLAURI E. Probiotics: A novel approach in the management of food allergy. J Allergy Clin Immunol 1997: 99: 179-85.
13. HELIN T, HAAHTELA S, HAAHTELA T. No effect of treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy 2002: 57: 243-6.
14. ISOLAURI E, MAJAMAA H, ARVOLA T, RANTALA I, VIRTANEN E, ARVILOMMI H. Lactobacillus casei strain GG reverse increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology 1993: 105: 1643-50.
15. KIRJAVAINEN PV, APOSTOLOU E, ARVOLA T, SALMINEN SJ, GIBSON GR, ISOLAURI E. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. Immunol Med Microbiol 2001: 32: 1-7.
16. MATSZAKI T, CHIN J. Modulating immune responses with probiotic bacteria. Immunol Cell Biol 2000: 78: 67-73.
17. + T cells with low proliferative capacity that produce transforming growth factor β and interleukin-10. Clin Diagn Lab Immunol 2001: 8: 695-701.
18. PESSI T, SÜTAS Y, HURME M, ISOLAURI E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 2000: 30: 1804-8.
19. BRIGHTBILL HD, LIBRATY DH, KRUTZIK SR, et al. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 1999: 285: 732-6.
20. DONOHUE DC, DEIGHTON M, AHOKAS JT. Toxicity of lactic acid bacteria. In: SALMINEN S, VON WRIGHT A, eds. Lactic Acid Bacteria. New York: Marcel Dekker Inc. 1993: 307-13.
21. SALMINEN MK, TYNKKYNEN S, REUTELIN H, et al. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 2002: 35: 1155-60.